380 related articles for article (PubMed ID: 1394026)
1. A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression.
Bakish D; Wiens A; Ellis J; Alda M; Lapierre Y
Can J Psychiatry; 1992 Sep; 37 Suppl 1():12-7. PubMed ID: 1394026
[TBL] [Abstract][Full Text] [Related]
2. Thyroid functioning during treatment for depression.
Kusalic M; Engelsmann F; Bradwejn J
J Psychiatry Neurosci; 1993 Nov; 18(5):260-3. PubMed ID: 8297924
[TBL] [Abstract][Full Text] [Related]
3. Controlled comparison of RO 11-1163 (moclobemide) and placebo in the treatment of depression.
Botte L; Evrard JL; Gilles C; Stenier P; Wolfrum C
Acta Psychiatr Belg; 1992; 92(6):355-69. PubMed ID: 1345409
[TBL] [Abstract][Full Text] [Related]
4. Moclobemide, imipramine, and placebo in the treatment of major depression (DSM III).
Versiani M; Nardi AE; Mundim FD; Alves AB
J Neural Transm Suppl; 1989; 28():65-75. PubMed ID: 2794994
[TBL] [Abstract][Full Text] [Related]
5. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
Bremner JD
J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
[TBL] [Abstract][Full Text] [Related]
6. A double blind trial of moclobemide versus amitriptyline in the treatment of depressive disorders.
Newburn GM; Fraser AR; Menkes DB; Mullen PE
Aust N Z J Psychiatry; 1990 Dec; 24(4):475-9. PubMed ID: 2073222
[TBL] [Abstract][Full Text] [Related]
7. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
Kok LP; Tsoi WF
Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
[TBL] [Abstract][Full Text] [Related]
8. Moclobemide versus amitriptyline in the treatment of depression: two small double-blind multicentre studies in Belgium.
Beckers G; Vereecken A; de Bleeker E; Jaunes C; Sieben G; Faidherbe J; Wolfrum C; Berger M; Hellstern K; Ward J
Acta Psychiatr Scand Suppl; 1990; 360():52-3. PubMed ID: 2248072
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression.
Reimherr FW; Chouinard G; Cohn CK; Cole JO; Itil TM; LaPierre YD; Masco HL; Mendels J
J Clin Psychiatry; 1990 Dec; 51 Suppl B():18-27. PubMed ID: 2258378
[TBL] [Abstract][Full Text] [Related]
10. An Australian multicentre study of moclobemide versus amitriptyline in the treatment of depression.
Evans L; George T; O'Sullivan B; Mitchell P; Johnson G; Adena M
Aust N Z J Psychiatry; 1992 Sep; 26(3):454-8. PubMed ID: 1417632
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
König F; Wolfersdorf M
Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
[TBL] [Abstract][Full Text] [Related]
12. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
[TBL] [Abstract][Full Text] [Related]
13. A comparison of moclobemide, amitriptyline and placebo in depression: a Canadian multicentre study.
Bakish D; Bradwejn J; Nair N; McClure J; Remick R; Bulger L
Psychopharmacology (Berl); 1992; 106 Suppl():S98-101. PubMed ID: 1546154
[TBL] [Abstract][Full Text] [Related]
14. Fluoxetine compared with amitriptyline in elderly depression: a controlled clinical trial.
Altamura AC; De Novellis F; Guercetti G; Invernizzi G; Percudani M; Montgomery SA
Int J Clin Pharmacol Res; 1989; 9(6):391-6. PubMed ID: 2699465
[TBL] [Abstract][Full Text] [Related]
15. Treatment of atypical depression with moclobemide: a sequential double controlled study.
Schweitzer I; Tiller J; Maguire K; Davies B
Int J Clin Pharmacol Res; 1989; 9(2):111-7. PubMed ID: 2654034
[TBL] [Abstract][Full Text] [Related]
16. Moclobemide, imipramine and placebo in the treatment of major depression.
Versiani M; Nardi AE; Mundim FD; Alves A; Schmid-Burgk W
Acta Psychiatr Scand Suppl; 1990; 360():57-8. PubMed ID: 2248073
[TBL] [Abstract][Full Text] [Related]
17. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
Marchesi C; Ceccherininelli A; Rossi A; Maggini C
Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
[TBL] [Abstract][Full Text] [Related]
18. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
Ucha Udabe R; Márquez CA; Traballi CA; Portes N
Acta Psychiatr Scand Suppl; 1990; 360():54-6. PubMed ID: 2123367
[TBL] [Abstract][Full Text] [Related]
19. Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium.
Botte L; Gilles C; Evrard JL; Mesters P; Wolfrum C; Berger M; Hellstern K; Ward J
Acta Psychiatr Scand Suppl; 1990; 360():42. PubMed ID: 2248066
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of moclobemide compared with maprotiline in treatment of major depressive disorder. A double-blind multicenter study with parallel groups.
Steinmeyer EM; Vorbach EU; Arnoldt KH
Pharmacopsychiatry; 1993 Nov; 26(6):246-53. PubMed ID: 8127929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
